T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
MacroGenics
MGNX
$100M
| $4.13M | ﹤0.01% |
1,254,236
-82,784
| -6% | -$272K |
|
1352
Wyndham Hotels & Resorts
WH
$6.55B
| $4.13M | ﹤0.01% |
52,808
+2,211
| +4% | +$173K |
|
1353
Matsons
MATX
$3.29B
| $4.12M | ﹤0.01% |
28,856
+703
| +2% | +$100K |
|
1354
Brady Corp
BRC
$3.74B
| $4.09M | ﹤0.01% |
53,388
-634
| -1% | -$48.6K |
|
1355
Gentex
GNTX
$6.25B
| $4.09M | ﹤0.01% |
137,729
+6,903
| +5% | +$205K |
|
1356
Glacier Bancorp
GBCI
$5.8B
| $4.07M | ﹤0.01% |
88,913
+3,632
| +4% | +$166K |
|
1357
iShares Russell Mid-Cap Value ETF
IWS
$14.2B
| $4.06M | ﹤0.01% |
30,708
| – | – |
|
1358
Glaukos
GKOS
$4.75B
| $4.03M | ﹤0.01% |
30,955
-1,681
| -5% | -$219K |
|
1359
Coca-Cola Europacific Partners
CCEP
$40.7B
| $4.03M | ﹤0.01% |
51,169
+4,531
| +10% | +$357K |
|
1360
Prosperity Bancshares
PB
$6.44B
| $4.02M | ﹤0.01% |
55,774
+3,698
| +7% | +$267K |
|
1361
WSFS Financial
WSFS
$3.13B
| $3.99M | ﹤0.01% |
78,151
-124,438
| -61% | -$6.35M |
|
1362
Flywire
FLYW
$1.63B
| $3.98M | ﹤0.01% |
242,717
-496,851
| -67% | -$8.15M |
|
1363
HF Sinclair
DINO
$9.56B
| $3.97M | ﹤0.01% |
89,055
+6,099
| +7% | +$272K |
|
1364
Viking Therapeutics
VKTX
$2.79B
| $3.97M | ﹤0.01% |
62,669
+2,999
| +5% | +$190K |
|
1365
Commerce Bancshares
CBSH
$7.96B
| $3.97M | ﹤0.01% |
70,077
+1,861
| +3% | +$105K |
|
1366
Dole
DOLE
$1.3B
| $3.96M | ﹤0.01% |
243,126
+29,867
| +14% | +$487K |
|
1367
Travere Therapeutics
TVTX
$2.09B
| $3.94M | ﹤0.01% |
281,349
+247,908
| +741% | +$3.47M |
|
1368
Kite Realty
KRG
$4.95B
| $3.91M | ﹤0.01% |
147,315
+2,218
| +2% | +$58.9K |
|
1369
SEI Investments
SEIC
$10.7B
| $3.91M | ﹤0.01% |
56,422
+2,988
| +6% | +$207K |
|
1370
Thor Industries
THO
$5.55B
| $3.9M | ﹤0.01% |
35,464
+1,730
| +5% | +$190K |
|
1371
Arcosa
ACA
$4.67B
| $3.84M | ﹤0.01% |
40,517
+90
| +0.2% | +$8.53K |
|
1372
Wintrust Financial
WTFC
$9.08B
| $3.83M | ﹤0.01% |
35,247
+5,868
| +20% | +$637K |
|
1373
Zentalis Pharmaceuticals
ZNTL
$107M
| $3.82M | ﹤0.01% |
1,036,911
+113,010
| +12% | +$416K |
|
1374
Alector
ALEC
$278M
| $3.81M | ﹤0.01% |
816,458
-53,120
| -6% | -$248K |
|
1375
iShares Russell Mid-Cap Growth ETF
IWP
$20.6B
| $3.8M | ﹤0.01% |
32,352
| – | – |
|